Genome-Wide Association Study Identifies Candidate Loci Associated with Opioid Analgesic Requirements in the Treatment of Cancer Pain

SIMPLE SUMMARY: Pain is experienced by ~55% of patients who undergo anti-cancer treatment. However, many genetic factors that are involved in the efficacy of opioid analgesics in the treatment of cancer pain remain unidentified. The aim of our genome-wide association study (GWAS) was to comprehensiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishizawa, Daisuke, Terui, Takeshi, Ishitani, Kunihiko, Kasai, Shinya, Hasegawa, Junko, Nakayama, Kyoko, Ebata, Yuko, Ikeda, Kazutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564079/
https://www.ncbi.nlm.nih.gov/pubmed/36230616
http://dx.doi.org/10.3390/cancers14194692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564079/
https://www.ncbi.nlm.nih.gov/pubmed/36230616
http://dx.doi.org/10.3390/cancers14194692

Ejemplares similares